Eligibility for antiamyloid treatment: preparing for disease-modifying therapies for Alzheimer's disease.

While a sizeable proportion of patients attending memory clinics may be referred for triaging for DMTs for AD, only a minority are likely to be suitable for these, as demonstrated in patients seen in specialist cognitive services. This will need to be considered when designing pathways for DMT delivery.